LANNETT CO INC FDA Approval ANDA 203564

ANDA 203564

LANNETT CO INC

FDA Drug Application

Application #203564

Documents

Letter2014-11-05

Application Sponsors

ANDA 203564LANNETT CO INC

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL10MG/ML0LAMIVUDINELAMIVUDINE

FDA Submissions

UNKNOWN; ORIG1AP2014-10-31

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAA

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 203564
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LAMIVUDINE","activeIngredients":"LAMIVUDINE","strength":"10MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/31\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2014\\\/203564Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-10-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.